Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

matti lehtinen

Karolinska University Hospital

Sweden

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Health Communication

30%

Virology

80%

Cervical Cancer

100%

Cancer Biology

50%

Cancer Prevention

40%

Human Papillomavirus

40%

Immunization

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles18

Elevated Risk of HPV‐Associated Oropharyngeal Cancers in Husbands of Women With Anogenital Cancer

Article Link

Year:

2025

Scientific approaches to defining HPV vaccine‐induced protective immunity

Article Link

Year:

2025

Elimination of cervical cancer by refined vaccination and screening

Article Link

Year:

2025

Scientific approaches toward improving cervical cancer elimination strategies

Article Link

Year:

2024

Assessing the risk of cervical neoplasia in the post‐HPV vaccination era

Article Link

Year:

2023

HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study.

Article Link

Year:

2023

Human papillomavirus genotype replacement: Cstill too early to tell?

Article Link

Year:

2021

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs

Article Link

Year:

2021

Elimination of HPV-associated oropharyngeal cancers in Nordic countries

Article Link

Year:

2021

Preterm birth rate after bivalent HPV vaccination: Registry-based follow-up of a randomized clinical trial

Article Link

Year:

2021

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers

Article Link

Year:

2021

Effectiveness of various human papillomavirus vaccination strategies

Article Link

Year:

2021

Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries

Article Link

Year:

2020

Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project

Article Link

Year:

2020

Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women

Article Link

Year:

2020

Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank

Article Link

Year:

2020

Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial

Article Link

Year:

2020

Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials

Article Link

Year:

2020

Collaborators12

Karolina Louvanto

University of Tampere

FINLAND

Maria Hortlund

Karolinska Institutet

SWEDEN

Martin Widschwendter

University of Innsbruck

AUSTRIA

Ville Nikolai Pimenoff

Karolinska Institutet

SWEDEN

Sara Nordqvist Kleppe

Karolinska Institutet

SWEDEN

Johannes Bogaards

A/Prof

Amsterdam UMC

NETHERLANDS

Claudia Robles

Institut Català d'Oncologia

SPAIN

belinda nedjai

Associate Professor/ Reader in Cancer Biomarkers and Epigenetics molecular epidemiology

Queen Mary University of London

UNITED KINGDOM

Eduardo L. Franco

McGill University

CANADA

Nicolas Folschweiller

Head Clinical Development Leads Vaccines

Biogen (Switzerland)

SWITZERLAND

Joakim Dillner

Professor

Karolinska Institutet

SWEDEN

Jorma Paavonen

University of Helsinki

FINLAND

How do I reach out?

Meet Kite AI